Natixis Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.2M | Buy |
|
|||||
|
2025
Q2 | $9.4M | Buy |
|
|||||
|
2025
Q1 | $6.49M | Sell |
|
|||||
|
2024
Q4 | $15M | Buy |
|
|||||
|
2024
Q3 | $13.8M | Buy |
|
|||||
|
2024
Q2 | $9.08M | Buy |
|
|||||
|
2024
Q1 | $9.57M | Buy |
|
|||||
|
2023
Q4 | $6.7M | Buy |
|
|||||
|
2023
Q3 | $6.31M | Buy |
|
|||||
|
2023
Q2 | $4.36M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $6.71M | Sell |
|
|||||
|
2020
Q4 | $7.12M | Sell |
|
|||||
|
2020
Q3 | $6.59M | Buy |
|
|||||
|
2020
Q2 | $5.66M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $546K | Buy |
|
|||||
|
2014
Q1 | $578K | Buy |
|
|||||
|
2013
Q4 | $523K | Sell |
|
|||||
|
2013
Q3 | $542K | Sell |
|
|||||
|
2013
Q2 | $522K | Buy |
|